'The American health care system has joined with commercial partners to define sleep apnea in a way that allows both parties to generate revenue from a multitude of pricey diagnostic studies, equipment sales, and questionable treatments.'
A large study on obstructive sleep apnea and cancer risk finds severity index differences between patients with and without cancer.
New research suggests that many more OSA patients may clinically benefit from maxillomandibular advancement than sleep specialists assume.
Sommetrics is advancing activities aimed at obtaining US Food and Drug Administration (FDA) market clearance for its flagship product, aerSleep II, which is targeted for the treatment of obstructive sleep apnea in those unable to use CPAP therapy.
Neurostimulators don't have decades of patient data like CPAP, but Inspire and remedē's 1- and 5-year outcome studies show sustained benefits.
Continuous positive airway pressure (CPAP) may be a preferred alternative to noninvasive ventilation (NIV) as first-line therapy in stable ambulatory patients with obesity hypoventilation syndrome (OHS) and concurrent...
While those with sleep apnea did have more severe outcomes with COVID-19, they were not at a higher risk for contracting the virus.
Camarillo, Calif-based Green Pharmaceuticals Inc is voluntarily recalling lot 2373/21222 of SnoreStop NasoSpray.